Get the Stockscreener App
11.42
0.50%
0.0543
Angiodynamic Inc stock is traded at $11.42, with a volume of 301.73K.
It is up +0.50% in the last 24 hours and down -0.11% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$11.37
Open:
$11.43
24h Volume:
301.73K
Relative Volume:
0.58
Market Cap:
$470.70M
Revenue:
$307.31M
Net Income/Loss:
$-27.71M
P/E Ratio:
-16.97
EPS:
-0.6732
Net Cash Flow:
$-15.27M
1W Performance:
+1.85%
1M Performance:
-0.11%
6M Performance:
+3.23%
1Y Performance:
+18.29%
1-Day Range:
$11.37
$11.58
1-Week Range:
$10.63
$11.58
52-Week Range:
$8.36
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
11.42 | 468.64M | 307.31M | -27.71M | -15.27M | -0.6732 |
ISRG
Intuitive Surgical Inc
|
467.03 | 163.73B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.11 | 44.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.58 | 36.73B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.48 | 36.12B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
221.78 | 32.70B | 5.40B | 1.49B | 1.78B | 10.12 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Initiated | Lake Street | Buy |
| Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-25-23 | Initiated | H.C. Wainwright | Buy |
| Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-20-21 | Initiated | Oppenheimer | Perform |
| Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Feb-08-17 | Initiated | Barclays | Equal Weight |
| Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-08-16 | Resumed | Piper Jaffray | Neutral |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
| Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
| Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0% - Defense World
Vanguard disaggregates holdings; reports 0 shares in AngioDynamics (ANGO) - Stock Titan
AngioDynamics schedules April 2 earnings call before market open - Stock Titan
AngioDynamics, Inc. $ANGO Shares Acquired by Divisadero Street Capital Management LP - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates - Finviz
AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 17.6% - MarketBeat
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz
Hear AngioDynamics CEO Jim Clemmer live at Leerink healthcare conference - Stock Titan
Can AngioDynamics Inc. stock maintain growth trajectoryWeekly Trade Review & Fast Gain Stock Trading Tips - mfd.ru
Is AngioDynamics Inc. a top pick in the sectorAnalyst Upgrade & Verified Technical Signals - mfd.ru
Bastion Asset Management Inc. Buys 304,960 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Will AngioDynamics Inc. benefit from rate cutsEarnings Risk Summary & Technical Confirmation Trade Alerts - mfd.ru
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth - Finviz
Is AngioDynamics Inc. stock influenced by commodity prices2025 Earnings Impact & Proven Capital Preservation Tips - mfd.ru
Essex Investment Management Co. LLC Increases Holdings in AngioDynamics, Inc. $ANGO - MarketBeat
Kevin Kotler discloses 5.9% AngioDynamics (ANGO) stake in 13G filing - Stock Titan
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect? - Finviz
Here's Why You Should Add Masimo Stock to Your Portfolio Now - Finviz
AngioDynamics summit spotlights tools for clots and tough heart infections - Stock Titan
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Finviz
Is AngioDynamics Inc. stock a smart retirement pick2025 Trading Recap & Weekly Stock Performance Updates - Mfd.ru
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring An 81.88% Potential Upside - DirectorsTalk Interviews
Fed Watch: What is XPO Inc.’s market positionWall Street Watch & Smart Allocation Stock Tips - baoquankhu1.vn
Portfolio Update: Will AngioDynamics Inc stock benefit from M AEarnings Overview Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
RSI Check: Why is AngioDynamics Inc stock going down2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
AngioDynamics Inc Presents at J.P. Morgan Healthcare Conference - TradingView
AngioDynamics to lay off 54 workers in Glens Falls, Queensbury - timesunion.com
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts - Finviz
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Finviz
Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - simplywall.st
How AngioDynamics Inc. stock reacts to oil pricesJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Earnings Beat: Why AngioDynamics Inc. stock is seen as undervaluedWeekly Investment Report & Entry Point Confirmation Alerts - Улправда
Is AngioDynamics Inc. stock a defensive play in 2025Portfolio Risk Report & Low Risk Entry Point Tips - Улправда
Why AngioDynamics Inc. stock is seen as undervaluedMarket Growth Summary & Low Risk Profit Maximizing Plans - Улправда
Why AngioDynamics Inc. (UG2) stock remains top rated2025 Dividend Review & High Win Rate Trade Tips - Улправда
Will AngioDynamics Inc. stock benefit from commodity prices2025 Short Interest & Accurate Buy Signal Alerts - ulpravda.ru
Why AngioDynamics Inc. stock is recommended by analystsJuly 2025 Selloffs & Smart Allocation Stock Tips - Улправда
Is AngioDynamics' (ANGO) Higher Sales Guidance Enough To Offset CEO Transition Concerns? - Yahoo Finance
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript - Insider Monkey
AngioDynamics Q2 Earnings Call Highlights - Defense World
ANGIODYNAMICS INC SEC 10-Q Report - TradingView — Track All Markets
AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Revises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8% - AlphaStreet
Why hedge funds are buying AngioDynamics Inc. stock2026 world cup usa national team third place match young talents pressing system match prediction breakdown - ulpravda.ru
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Angiodynamic Inc Stock (ANGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Trowbridge Stephen A | EVP and CFO |
Oct 13 '25 |
Buy |
11.16 |
890 |
9,932 |
256,629 |
| Clemmer James C | President and CEO |
Oct 09 '25 |
Buy |
11.15 |
10,000 |
111,500 |
882,529 |
0.09%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):